261 related articles for article (PubMed ID: 20619755)
1. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis.
Vítek L; Zelenková M; Brůha R
Dig Liver Dis; 2010 Dec; 42(12):911-2. PubMed ID: 20619755
[No Abstract] [Full Text] [Related]
2. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
3. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
Poupon R; Chrétien Y; Chazouillères O; Poupon RE
J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
[No Abstract] [Full Text] [Related]
4. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares Rodríguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
5. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Serfaty L; Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
[No Abstract] [Full Text] [Related]
6. Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom.
Corpechot C; Poupon R
Hepatology; 2007 Oct; 46(4):963-5. PubMed ID: 17894325
[No Abstract] [Full Text] [Related]
7. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Makino I
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
[No Abstract] [Full Text] [Related]
8. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
9. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-].
Rudi J; Schönig T; Stremmel W
Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
11. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
[TBL] [Abstract][Full Text] [Related]
12. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
Yan G; Erik C; Gluud C
Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
[No Abstract] [Full Text] [Related]
13. [Interview: questions to Professor Raoul Poupon].
Poupon R
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):333-7. PubMed ID: 12700521
[No Abstract] [Full Text] [Related]
14. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
[TBL] [Abstract][Full Text] [Related]
15. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
Mayo MJ
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Treiber G; Malfertheiner P
J Clin Gastroenterol; 2005 Oct; 39(9):837-8; author reply 838. PubMed ID: 16145353
[No Abstract] [Full Text] [Related]
17. Primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
[No Abstract] [Full Text] [Related]
18. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurova FKh
Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]